Noah Hahn, MD

Articles by Noah Hahn, MD

ADAPT-BLADDER Cohort 4: A Phase 1/2 Trial of Durvalumab Plus Intravesical Gemcitabine and Docetaxel in BCG-Unresponsive NMIBC

Noah Hahn, MDUrothelial Carcinoma | February 24, 2025

Noah Hahn, MD, gives an overview of durvalumab with intravesical gemcitabine and docetaxel for BCG-unresponsive NMIBC.